Evidence map›Paper›PMID 37132608›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

From Microscopic Droplets to Macroscopic Crowds: Crossing the Scales in Models of Short-Range Respiratory Disease Transmission, with Application to COVID-19.

Simon Mendez, Willy Garcia, Alexandre Nicolas

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Simon MendezIMAG, Univ. Montpellier, CNRS, Montpellier, F-34095, France.ORCID 0000-0002-0863-2024
Willy GarciaInstitut Lumière Matière, CNRS, Univ. Claude Bernard Lyon 1, Villeurbanne, F-69622, France.ORCID 0000-0003-0285-6083
Alexandre NicolasInstitut Lumière Matière, CNRS, Univ. Claude Bernard Lyon 1, Villeurbanne, F-69622, France.ORCID 0000-0002-8953-3924
Université Claude Bernard Lyon 1 · FRCentre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche ANR-20-COV1-0003Agence Nationale de la Recherche ANR-21-CO15-0002
6 · The paper itself

Abstract

Short-range exposure to airborne virus-laden respiratory droplets is an effective transmission route of respiratory diseases, as exemplified by Coronavirus Disease 2019 (COVID-19). In order to assess the risks associated with this pathway in daily-life settings involving tens to hundreds of individuals, the chasm needs to be bridged between fluid dynamical simulations and population-scale epidemiological models. This is achieved by simulating droplet trajectories at the microscale in numerous ambient flows, coarse-graining their results into spatio-temporal maps of viral concentration around the emitter, and coupling these maps to field-data about pedestrian crowds in different scenarios (streets, train stations, markets, queues, and street cafés). At the individual scale, the results highlight the paramount importance of the velocity of the ambient air flow relative to the emitter's motion. This aerodynamic effect, which disperses infectious aerosols, prevails over all other environmental variables. At the crowd's scale, the method yields a ranking of the scenarios by the risks of new infections, dominated by the street cafés and then the outdoor market. While the effect of light winds on the qualitative ranking is fairly marginal, even the most modest air flows dramatically lower the quantitative rates of new infections.

Indexed as

COVID-19Respiration DisordersRespiratory Tract DiseasesHumansRespiratory Aerosols and Dropletscrowd dynamicsepidemiologyfluid dynamicsrespiratory droplets

Identifiers

PMID37132608
PMCPMC10323631
OpenAlexW4291316005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.